HEPATITIS B VIRUS CORE ANTIGEN
Recombinantly created Hepatitis B Virus center antigen (HBcAg). This center protein section addresses part of the irresistible virions internal center molecule, which encases the viral genome.
Item DETAILS – HEPATITIS B VIRUS CORE ANTIGEN
Recombinant Hepatitis B infection Core protein created in E. coli.
Contains HBV Core immunodominant district.
Accessible in fluid arrangement and cushioned in 10 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA, half glycerol.
More prominent than 90% virtue by SDS-PAGE.
Immunoreactive with serum of HBV tainted people.
Foundation
HBV is a wrapped DNA infection with a 3.2-kb covalently shut roundabout DNA, which imitates inside the core of contaminated hepatocytes (Seeger and Mason, 2015). Profoundly, polymerase (P), envelope (pre-S1/pre-S2/S) and X. The pre-center/center quality is answerable for articulation of center protein as well as hepatitis B e antigen (HBeAg), a serological marker of HBV contamination corresponding with high popular burden.
The 5′ finish of pre-S1, pre-S2 and S districts all have autonomous beginning codons which can each produce three co-terminal envelope proteins called enormous (L; pre-S1 pre-S2 S), center (M; pre-S2 S), and little (S; with S area alone) envelope proteins. The S protein is the most plentiful envelope protein communicated and can be discharged freely of L and M envelope proteins. After emission, mature HBeAg is erased at buildup 149 C-terminally and holds 10 pre-center deposits N-terminally. Both L and S envelope proteins are required for virion emission, while M protein is nonessential (Bruss and Ganem, 1991; Ueda et al., 1991).
Hepatitis B virus |
|||
PCR-H494-PCRH49448D | Bioingentech | PCR-H494-48D | 230 EUR |
Hepatitis B virus |
|||
PCR-H494-PCRH49496D | Bioingentech | PCR-H494-96D | 312 EUR |
Hepatitis B virus |
|||
Oneq-H494-OneqH494100D | Bioingentech | Oneq-H494-100D | 515 EUR |
Hepatitis B virus |
|||
Oneq-H494-OneqH494150D | Bioingentech | Oneq-H494-150D | 594 EUR |
Hepatitis B virus |
|||
Oneq-H494-OneqH49450D | Bioingentech | Oneq-H494-50D | 413 EUR |
Hepatitis B Virus |
|||
MBS320140-01mg | MyBiosource | 0.1mg | 355 EUR |
Hepatitis B Virus |
|||
MBS320140-5x01mg | MyBiosource | 5x0.1mg | 1500 EUR |
Hepatitis B Virus |
|||
MBS320141-01mg | MyBiosource | 0.1mg | 355 EUR |
Hepatitis B Virus |
|||
MBS320141-5x01mg | MyBiosource | 5x0.1mg | 1500 EUR |
Hepatitis B Virus |
|||
MBS320142-01mg | MyBiosource | 0.1mg | 355 EUR |
Hepatitis B Virus |
|||
MBS320142-5x01mg | MyBiosource | 5x0.1mg | 1500 EUR |
Hepatitis B virus |
|||
MBS328007-01mg | MyBiosource | 0.1mg | 595 EUR |
Hepatitis B virus |
|||
MBS328007-5x01mg | MyBiosource | 5x0.1mg | 2595 EUR |
Hepatitis B virus |
|||
MBS328008-01mg | MyBiosource | 0.1mg | 595 EUR |
Hepatitis B virus |
|||
MBS328008-5x01mg | MyBiosource | 5x0.1mg | 2595 EUR |
Hepatitis B virus |
|||
MBS328009-01mg | MyBiosource | 0.1mg | 595 EUR |
Hepatitis B virus |
|||
MBS328009-5x01mg | MyBiosource | 5x0.1mg | 2595 EUR |
Hepatitis B virus |
|||
MBS328014-01mg | MyBiosource | 0.1mg | 435 EUR |
Center particles with mature (twofold abandoned DNA) genome can be encompassed and delivered as 42-nm virions, with the three envelope proteins embedded on a superficial level. Void viral particles (22-nm) are additionally bounteously delivered (Bruss and Ganem, 1991; Ganem and Prince, 2004; Zhang and Tang, 2017). HBcAg is one of the three significant clinical antigens of hepatitis B infection yet vanishes from the get-go throughout disease. It is an exceptionally immunogenic subviral molecule including 180 or 240 duplicates of the center protein and capacities as both a T-cell-reliant and a T-cell-free antigen.